Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinson's disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible (unlike those of lesioning techniques), and it is one of only a few neurosurgical methods that allow blinded studies.
Increasing prevalence of neurological disorders is one of the critical factors driving the growth of this market globally. With more than 450 million people worldwide affected by neurological disorders, such as Alzheimer disease, brain injuries, epilepsy, Parkinson’s disease (PD), strokes, peripheral neuropathy, and paralysis, the market for DBS has a positive outlook in the coming years. For instance, PD is a progressive neurological disorder that affects the central nervous system resulting in muscle stiffness and slow movement. Although PD cannot be cured completely with medicines, DBS is preferred as it can be used to improve motor symptoms. Moreover, in cases of neurological injuries that lead to paralysis or disability, DBS can be used to restore movement, reduce tremor and dyskinesia, and improve the quality of life. Furthermore, DBS also helps in improving bladder control, restoring hand grasp, and improving walking in patients. Therefore, the increasing number of neurological disorders will bolster the growth of this market in the coming years.
The global Deep Brain Stimulation (DBS) market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Deep Brain Stimulation (DBS) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Deep Brain Stimulation (DBS) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Deep Brain Stimulation (DBS) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Single-channel DBS
Dual-channel DBS
Segment by Application
Parkinson's Disease
Essential Tremor
Dystonia
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Medtronic
Boston Scientific
Abbott
Beijing Pins
SceneRay
Increasing prevalence of neurological disorders is one of the critical factors driving the growth of this market globally. With more than 450 million people worldwide affected by neurological disorders, such as Alzheimer disease, brain injuries, epilepsy, Parkinson’s disease (PD), strokes, peripheral neuropathy, and paralysis, the market for DBS has a positive outlook in the coming years. For instance, PD is a progressive neurological disorder that affects the central nervous system resulting in muscle stiffness and slow movement. Although PD cannot be cured completely with medicines, DBS is preferred as it can be used to improve motor symptoms. Moreover, in cases of neurological injuries that lead to paralysis or disability, DBS can be used to restore movement, reduce tremor and dyskinesia, and improve the quality of life. Furthermore, DBS also helps in improving bladder control, restoring hand grasp, and improving walking in patients. Therefore, the increasing number of neurological disorders will bolster the growth of this market in the coming years.
The global Deep Brain Stimulation (DBS) market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Deep Brain Stimulation (DBS) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Deep Brain Stimulation (DBS) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Deep Brain Stimulation (DBS) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Single-channel DBS
Dual-channel DBS
Segment by Application
Parkinson's Disease
Essential Tremor
Dystonia
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Medtronic
Boston Scientific
Abbott
Beijing Pins
SceneRay
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.